PDF herunterladen
Synlett 2005(4): 637-639  
DOI: 10.1055/s-2005-862390
LETTER
© Georg Thieme Verlag Stuttgart · New York

Stereoselective Synthesis of Condensed Aza-d-homo-estrone Derivatives by 1,3-Dipolar Cycloaddition

Erzsébet Mernyák, Gabriella Benedek, Gyula Schneider, János Wölfling*
Department of Organic Chemistry, University of Szeged, Dóm tér 8., 6720 Szeged, Hungary
Fax: +36(62)544200; e-Mail: wolfling@chem.u-szeged.hu;
Weitere Informationen

Publikationsverlauf

Received 14 December 2004
Publikationsdatum:
22. Februar 2005 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

The halogen-induced intramolecular formation of 13α- and 13β-estrone nitrones, followed by 1,3-dipolar cycloaddition reactions with N-phenylmaleimide (NPM) stereoselectively furnished halogen-containing condensed heterocyclic d-homosteroids.

Key words

Estrone - d-homosteroids - 1,3-dipolar cycloadditions - stereoselective synthesis - halogenation

    References

  • 1a 1,3-Dipolar Cycloaddition Chemistry   Padwa A. Wiley; New York: 1984. 
    CrossrefGoogle Scholar
  • 1b Pérez P. Domingo LR. Aurell MJ. Contreras R. Tetrahedron  2003,  59:  3117 
    CrossrefGoogle Scholar
  • 2a Dondas HA. Grigg R. Hadjisoteriu M. Markandu J. Thomas WA. Kennewell P. Tetrahedron  2000,  56:  10087 
    CrossrefGoogle Scholar
  • 2b Dondas HA. Grigg R. Hadjisoteriu M. Markandu J. Kennewell P. Thornton-Pett M. Tetrahedron  2001,  57:  1119 
    CrossrefGoogle Scholar
  • 2c Dunn PJ. Graham AB. Grigg R. Saba IS. Thornton-Pett M. Tetrahedron  2002,  58:  7701 
    CrossrefGoogle Scholar
  • 3 Frank É. Wölfling J. Aukszi B. König V. Schneider TR. Schneider G. Tetrahedron  2002,  58:  6843 
    CrossrefGoogle Scholar
  • 4a Schönecker B. Lange C. Kötteritzsch M. Günther W. Weston J. Anders E. Görls H. J. Org. Chem.  2000,  65:  5487 
    Google Scholar
  • 4b Altona C. Geise HJ. Romers C. Tetrahedron  1968,  24:  13 
    Google Scholar
  • 4c Mernyák E. Schönecker B. Lange C. Kötteritzsch M. Görls H. Wölfling J. Schneider G. Steroids  2003,  68:  289 
    Google Scholar
  • 4d Nambara T. Kudo T. Hosoda H. Titaka Y. Kikutani N. Chem. Pharm. Bull.  1975,  23:  320 
    Google Scholar
  • 4e Nambara T. Kudo T. Chem. Pharm. Bull.  1972,  20:  2156 
    Google Scholar
  • 5a Frank É. Mernyák E. Wölfling J. Schneider G. Synlett  2002,  1803 
    CrossrefGoogle Scholar
  • 5b Wölfling J. Frank É. Mernyák E. Bunkóczi G. Cuesta Seijo JA. Schneider G. Tetrahedron  2002,  58:  6851 
    CrossrefGoogle Scholar
  • 6a Mernyák E. Wölfling J. Bunkóczi G. Luo L. Schneider TR. Schneider G. Collect. Czech. Chem. Commun.  2003,  68:  1141 
    Google Scholar
  • 6b Wölfling J. Mernyák E. Forgó P. Schneider G. Steroids  2003,  68:  451 
    Google Scholar
  • 6c Schneider G. Bottka S. Hackler L. Wölfling J. Sohár P. Liebigs Ann. Chem.  1989,  263 
    Google Scholar
7

General Procedure for the Synthesis of 16-Bromomethyl Cycloadducts (7a, 8a).
Compound 3 or 4 (100 mg, ca. 0.33 mmol) was dissolved in CH2Cl2, and DDH (50 mg, ca. 0.17 mmol) or NBS (60 mg, 0.33 mmol) was added. The mixture was then stirred at r.t. for 0.5 h and the solvent was evaporated off. The crude product was dissolved in benzene (5 mL), NPM (58 mg, ca. 0.33 mmol) was added and the solution was stirred at 50 °C for 2 h. After evaporation of the solvent, purification by column chromatography with tert-butyl-methyl ether (30%)-hexane (70%) as eluent yielded 145 mg (81%) of 7a: mp 132-137 °C; R f = 0.33 (CH2Cl2). 1H NMR (CDCl3): δ = 1.38 (s, 3 H, 18-H3), 2.87 (m, 2 H, 6-H2), 3.42 (dd, 1 H, J = 9.9 Hz, J = 8.0 Hz, 16a-H), 3.80 (dd, 1 H, J = 9.9 Hz, J = 2.2 Hz, 16a-H), 3.44 (d, 1 H, J = 8.0 Hz, 17a-H), 3.78 (s, 3 H, 3-OMe), 4.33 (t, 1 H, J = 8.0 Hz, 4′-H), 5.09 (d, 1 H, J = 8.0 Hz, 3′-H), 6.64 (d, 1 H, J = 2.4 Hz, 4-H), 6.73 (dd, 1 H, J = 8.6 Hz, J = 2.4 Hz, 2-H), 7.23-7.26 and 7.46 (overlapping multiplets, 5 H, 1-, 2′′-, 3′′-, 5′′-, 6′′-H), 7.40 (t, 1 H, J = 7.3 Hz, 4′′-H) ppm. 13C NMR (CDCl3): δ = 26.4, 27.4, 27.7, 29.8, 34.3 (C-18), 34.9, 36.4, 36.6, 38.3, 42.0, 45.0, 50.3, 55.2, 55.6, 74.6 (C-17a), 77.3 (C-3′), 111.9 (C-2), 113.4 (C-4), 126.4 and 129.2 (2 × 2 C, C-2′′, -3′′, -5′′, -6′′), 126.7 (C-1), 129.0 (C-4′′), 131.1 and 132.3 (2 ¥ l C, C-1′′ and C-10), 137.6 (C-5), 157.8 (C-3), 170.8 and 173.6 (2 ¥ l C, C-2′ and C-5′) ppm. Compound 8a was purified by chromatography with CH2Cl2 as eluent, yielding 120 mg (67%) of the pure product: mp 155-158 °C; R f = 0.25 (CH2Cl2). 1H NMR (CDCl3): δ = 1.22 (s, 3 H, 18-H3), 2.78 (m, 1 H, 4′-H), 2.88 (m, 2 H, 6-H2), 3.52 (dd, 1 H, J = 10.1 Hz, J = 7.3 Hz, 16a-H), 3.74 (m, 1 H, 16a-H), 3.54 (d, 1 H, J = 9.2 Hz, 17a-H), 3.77 (s, 3 H, 3-OMe), 5.20 (d, 1 H, J = 8.0 Hz, 3′-H), 6.64 (d, 1 H, J = 2.2 Hz, 4-H), 6.72 (dd, 1 H, J = 8.6 Hz, J = 2.2 Hz, 2-H), 7.20 (d, 1 H, J = 8.6 Hz, 1-H), 7.29 (d, 2 H, J = 7.8 Hz, 2′′-, 6′′-H), 7.41 (t, 1 H, J = 7.8 Hz, 4′′-H), 7.48 (t, 2 H, J = 7.8 Hz, 3′′-, 5′′-H). 13C NMR (CDCl3): δ = 21.3 (C-18), 25.3, 26.5, 28.2, 29.8, 35.4, 37.2, 37.4, 38.4, 41.1, 43.2, 48.5 (C-4′), 55.2 (3-OCH3), 61.2 (C-16), 77.3 (C-17a), 77.9 (C-3′), 111.7 (C-2), 113.5 (C-4), 126.2 and 128.9 (2 × 1 C, C-1 and C-4′′), 126.3 and 129.2 (2 × 2 C, C-2′′, -3′′, -5′′, -6′′), 131.1 and 131.9 (2 ¥ l C, C-1′′ and C-10), 137.5 (C-5), 157.6 (C-3), 170.9 and 173.2
(2 ¥ l C, C-2′and -5′).